Faecal Carriage and Antibiotics Resistance Patterns of Campylobacter Species from HIV/AIDS Patients in Ibadan, Southwest Nigeria

Main Article Content

Olutayo Israel Falodun
Emmanuel Adedapo Adesola
Ebenezer Adewuyi Ademola
Solomon A. Bakarey


Background: As a result of the low immunosuppressive condition of people living with Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS), they are at greater risk of Campylobacter infections but the use of antibiotics tends to reduce incidence. However, though this has reduced the incidence of the infection, there is likely development of antibiotic resistance with them thereby becoming asymptomatic carriers of drug resistant Campylobacter species.

Aim: This study was carried out to determine the faecal carriage and antibiotic susceptibility pattern of Campylobacter species isolated from HIV patients in Ibadan, Nigeria.

Methods: One Hundred stool samples were collected from HIV patients attending two Antiretroviral Clinics in Ibadan between February and March, 2017. Campylobacter species were isolated and identified using standard methods. Antibiotic susceptibility test of the isolates to amikacin, gentamycin, chloramphenicol, amoxicillin/clavulanate, cefixime, aztreonam, ciprofloxacin, cephalothin, nalidixic acid and ertapenem was done using disk diffusion method. 

Results: The prevalence of Campylobacter species in the stool samples of the HIV/AIDS patients was 68%. A total of one hundred and twenty isolates were identified as C. upsaliensis 32(26.7%), C. jejuni 30(25%), C. lari 23(19.2%), C. coli 20(16.7%), and C. fetus 15(12.5%). The antibiotics susceptibility pattern of these isolates showed that 97(80.8%), 88(73.3%), 82(68.3%), 9(7.5%), 9(7.5%) and 12 (10.8%) were resistant to gentamycin, chloramphenicol, cefixime, amikacin, ciprofloxacin and ertapenem respectively. Moreover, 102 (85.0%) of the isolates were found to be multidrug resistant.

Conclusions: The faecal carriage and high prevalence of antibiotic resistance of Campylobacter strains among the HIV/AIDS patients therefore present them as asymptomatic carrier and reservoir for dissemination of the bacteria.

Campylobacter species, antibiotic resistance, HIV and AIDS, Ibadan-Nigeria.

Article Details

How to Cite
Falodun, O. I., Adesola, E. A., Ademola, E. A., & Bakarey, S. A. (2020). Faecal Carriage and Antibiotics Resistance Patterns of Campylobacter Species from HIV/AIDS Patients in Ibadan, Southwest Nigeria. South Asian Journal of Research in Microbiology, 7(4), 39-46. https://doi.org/10.9734/sajrm/2020/v7i430181
Original Research Article


Ogbomon EO, Whong CMZ, Doko MHI, Magaji SN, Addai TI, Orukotan YF. Prevalence of Campylobacter spp. among diarrhoeic HIV-patients in Kaduna, Nigeria. Int J Appl Microb Biotech Res. 2019; 7:70-78.

Silva J, Leite D, Fernandes M, Mena C, Gibbs PA, Teixeira P. Campylobacter species as a foodborne pathogen: A review. Front Microbiol. 2011;2:200.

Pacanowski J, Valerie L, Karine L, Boudraa C, Lesprit P, Legrand P, et al. Campylobacter Bacteremia: Clinical Features and Factors Associated with Fatal Outcome. Clin Infect Dis. 2008;47: 790–796.

Salihu MD, Junaidu AU, Abubakar MB, Magaji AA, Mohammed LG. Isolation and Characterization of Campylobacter species from Camels (Camelus dramedarius) in Sokoto State, Northwestern, Nigeria. Int J Animal Vet Adv. 2009;1(1):25-27.

Adedayo O, Kirkpatrick BD. Campylobacter jejuni Infections: Update on presentation, diagnosis, and management. Hosp Physic. 2008:9-15.

Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev. 2015;28(3):687-720.

Igwaran A, Okoh AI. Human campylobacteriosis: A public health concern of global importance. Heliyon. 2019;5(11):e02814.

WHO. Campylobacter; 2020 Available:www.who.int/news-room/fact-sheets/detail/campylobacter Retrieved 22/9/2020.

Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q,Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 2009;4(2):189–200.

Adesiji YO, Oloke JK. Challenges of the Control of Opportunistic Infections of Zoonotic Origin in HIV/AIDS Patients. Int J Immunol. 2015;3(2):1-7.

Oladosu TO, Adebolu TT, Oladunmoye MK. Evaluation of the Types of Bacteria in the Blood of HIV-1 Patients Attending ART Clinic at the FMC Owo, Nigeria and their Antibiogram Profile. J HIV Curr Res. 2016; 1:103.

WHO. The global view of campylobacteriosis: Report of an expert consultation, Utrecht, Netherlands; 2012. Available:www.who.int/iris/bitstream/10665/80751/1/9789241564601_eng.pdf Retrieved 22/9/2020.

Bloomfield SJ, Midwinter AC, Biggs PJ, French NP, Marshall JC, Hayman DTS, et al. Long-term Colonization by Campylobacter jejuni within a Human Host: Evolution. Antimicrob Resist Adapt. 2018; 217:103–111.

CDC. Antibiotic resistance biggest threats; 2016. Available:https://www.cdc.gov/drugresistance/biggest-threats.html Retrieved 25/10/2019.

Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing M100S, 26th Edition; 2016.

Gwimi PB, Faleke OO, Salihu MD. Magaji AA, Abubakar MB, Nwankwo IO. et al. Prevalence of Campylobacter species in faecal samples of pigs and humans from Zuru Kebbi State, Nigeria. Int J One Health. 2015;1:1-5.

Nwankwo IO, Faleke OO, Salihu MD, Magaji AA, Musa U, Garba J, et al. Detection and viability of Campylobacter species isolates from different species of poultry and humans in Sokoto State, Nigeria. Int J One Healt. 2016;2:19-23.

Karikari, AB, Obiri-Danso K, Frimpong EH, Krogfelt KA. Antibiotic Resistance in Campylobacter Isolated from Patients with Gastroenteritis in a Teaching Hospital in Ghana. Open J of Med Microbiol. 2017; 7:1-11.

Lengerh A, Moges F, Unakal C, Anagaw B. Prevalence, associated risk factors and antimicrobial susceptibility pattern of Campylobacter species among under five diarrheic children at Gondar University Hospital, Northwest Ethiopia. BMC Ped. 2013;13:82.

Adekunle OC, Coker AO, Kolawole DO. Incidence, Isolation, and Characterization of Campylobacter species in Osogbo. Biol Med. 2009;1(1):24-27.

Tafa B, Sewunet T, Tassew H, Asrat D. Isolation and antimicrobial susceptibility patterns of campylobacter species among Diarrheic Children at Jimma, Ethiopia. Int J Bacteriol. 2014:560617.

Samie A, Ramalivhana J, Igumbor EO, Obi CL. Prevalence, Haemolytic and Haemagglutination Activities and Antibiotic Susceptibility Profiles of Campylobacter spp. Isolated from Human Diarrhoeal Stools in Vhembe District, South Africa. J Health Popul Nutr. 2007;25(4):406-413.

WHO. Campylobacter; 2018. Available:www.who.int/news-room/factsheets/details/campylobacter Retrieved 25/10/2019

Szczepanska B, Andrzejewska MI, Spica D, Klawe JJ. Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas. BMC Microbiol. 2017; 17:80.

Bravo1 F, Céspedes A, Morales P, Chanqueo L. Campylobacter jejuni bacteremia in a patient with HIV infection in AIDS stage. Rev Chilena Infectol. 2019; 36(5):663-666.

Simango C. Antimicrobial Susceptibility of Campylobacter Species. South Afri J Epidem Infec. 2013; 28(3):139-142.

Bester LA, Essack SY. Prevalence of antibiotic resistance in Campylobacter isolates from commercial poultry suppliers in KwaZulu-Natal, South Africa. J Antimicrob Chemother. 2008; 62:1298–1300.

Levesque S, Frost E, Michaud S. Comparison of Antimicrobial Resistance of Campylobacter jejuni Isolated from Humans, Chickens, Raw Milk, and Environmental Water in Quebec. J Food Protect. 2007;70(3):729–735.

Wardak S, Szych J, Zasada AA, Gierczynski R. Antibiotic Resistance of Campylobacter jejuni and Campylobacter coli Clinical Isolates from Poland. Antimicrob Agents Chemother. 2007; 51:1123–1125.